Jump to content


  • Posts

  • Joined

  • Last visited

  • Days Won


 Content Type 

Vaccine Safety Communication eLibrary

Everything posted by Admin

  1. Wondering how the mRNA vaccines are processed? Check out our newly released animation, “How mRNA Vaccines Work.”
  2. This infographic highlights the importance of getting children caught up on well-child visits and routine childhood vaccinations. The infographic is available to download and print.
  3. The latest on the COVID-19 global situation and monitoring vaccine safety. It is part of a larger pool of resources related to COVID-19 pandemic.
  4. Educational video on thrombosis with thrombocytopenia syndrome following adenoviruses vaccines against COVID-19.
  5. Training module The training module, in the form of presentation slides, provides a structured approach to assist health workers with interpersonal communication during COVID-19 vaccination consultations and is tailored to specific patient positions on vaccination. Participants are guided through 6 learning parts focusing on a combination of theory and practical skill building scenarios. Relevant COVID-19 vaccine and vaccination resources for health workers are provided to support vaccination consultations. This training is primarily for frontline health workers who will be vaccinators. Facilitator’s guide The Facilitator’s guide is designed to accompany the training module, providing detailed explanations and resources for all parts of the training module. A pre and post training self-reflection survey and post-training evaluation tool is also included. The facilitator’s guide is intended for training facilitators or Trainers of Trainers (ToTs) who will be conducting the training at the country level. Job aid The job aid is an interpersonal communication tool designed to support health workers in facilitating structured and collaborative COVID-19 vaccination conversations with patients, aiming to increase vaccine confidence and acceptance. It is intended for use in vaccination consultation settings.
  6. Pregnant women may safely receive inactivated vaccines, such as Tdap and the flu shot. They share everything with their babies. That means when a pregnant woman gets vaccines, she isn’t just protecting herself— she is giving the baby some early protection too.
  7. CDC regularly creates reports about the status of COVID-19 vaccine confidence in the United States, emphasizing major themes that influence vaccine confidence and uptake. The reports include analyses of multiple quantitative and qualitative data sources, ranging from social listening and web metrics to immunization survey data and CDC-INFO inquiries. The reports seek to identify emerging issues of misinformation, disinformation, and places where intervention efforts can positively increase vaccine confidence across the United States.
  8. Are the existing vaccines protective against all the COVID-19 variants of concern? Are the existing vaccines protective against all the COVID-19 variants of concern?
  9. Informations en français sur la sécurité des vaccins (Johnson & Johnson, Pfizer-BioNTech, Moderna) contre COVID-19.
  10. This programme consists of seven knowledge sessions with accompanying assessments. It is recommended that those new to immunisation complete all seven sessions. Those with prior knowledge and experience in immunisation may wish to read through the relevant knowledge sessions for refresher training or undertake the assessment sessions to check on their knowledge. Learners may also wish to only undertake the sessions relevant to their role. On completion of the knowledge sessions and assessments, users can print a certificate as evidence of the sessions undertaken. A period of supervised practice to allow acquisition and observation of clinical skills and application of knowledge to practice for practitioners new to immunisation is also recommended, as is the completion of an immunisation competency checklist.
  11. The National Foundation for Infectious Diseases (NFID) convened a multidisciplinary group of experts at a virtual roundtable in January 2021 to share research, insights, and best practices for improving and harmonizing communication to the public about the evolving COVID-19 pandemic and the importance of following evidence-based public health prevention measures.
  12. Updated resources regarding zoster vaccine for Australian adults: they include fact sheet, FAQs and a screening form for contraindications.
  13. Immunize Canada has assisted with developing the KT tools for the CARD system and the Hospital for SickKids (Toronto, Canada) through their AboutKidsHealth outreach program is also developing new tools for us to disseminate. These tools are for adults, children and healthcare providers ( https://immunize.ca/card-kids-and-adolescents ; https://immunize.ca/fr/systeme-card-pour-les-enfants-et-les-adolescents ; https://immunize.ca/fr/card-pour-les-adultes ; https://immunize.ca/card-adults ; https://immunize.ca/card ) and have been translated into French but CARD can be adapted to different local/cultural contexts and languages.
  14. COVAX, the largest and most complex global distribution of vaccines is under way, protecting the most vulnerable from COVID-19, wherever they are in the world. In order to end the acute phase of the pandemic and protect the world against the spread of new variants, the global roll-out must continue at unprecedented speed. The COVAX AMC has raised US$ 9.6 billion to date. This vital funding will enable COVAX to protect almost 30% of the population in 91 lower-income economies. But the COVAX delivery schedule has been hit hard by supply delays, and faces a supply shortfall of 190 million doses. To change the course of the pandemic, plug this short-term gap and help ensure equitable access to vaccines through COVAX: o Countries that have doses need to share them now – not later, when countries’ demand and ability to absorb doses will be met by hundreds of millions of doses that will be available through COVAX Facility deals. o Manufacturers need to prioritise COVAX. o Multilateral development banks must urgently release the funds to pay for health system preparedness to ensure countries can absorb the doses delivered. We call on the international community to reaffirm its support for the COVAX AMC and act urgently as One World Protected: Committed to Deliver.
  15. This document provides answers to some of the most frequently asked questions around coronavirus and the Covid-19 vaccine for a general public audience. This document will be updated regularly, and changes will be highlighted in yellow. Please look out for further iterations from your regional NHSEI communications team, and if in any doubt please check with them that you are using the latest version. Contents include: Coronavirus, About the Covid-19 vaccine, Covid-19 vaccine – eligibility, Covid-19 vaccine – timing, Covid-19 vaccine safety, Covid-19 vaccine side-effects, Covid-19 vaccine effectiveness, Covid-19 vaccine ingredients, Vaccine hesitancy, Second doses.
  16. A vaccine to prevent COVID-19 is likely to be the most effective way to control the pandemic. Scientists across the world have worked to develop vaccines which have then been rigorously tested for safety and efficacy. Those with a role in delivering/supporting the COVID-19 vaccine programme need to be knowledgeable, confident and competent in order to promote confidence in the vaccination programme and deliver the vaccine safely. The purpose of this pack is to ensure you have all the resources and information you need to hand, acting as a ‘go to guide’ to support you when talking with patients who are eligible for a Covid-19 vaccination but are showing signs of hesitancy. People may be concerned about or refusing the vaccine due to worries, fears, unclear about messages or for many other reasons. It’s important to understand that people will have their point of view and it may take time to talk through their concerns. Using Motivational Interviewing techniques, listening skills and sharing factual information about Covid-19 and the vaccine may help to encourage people and offer reassurance.
  17. The HHS "We Can Do This" campaign is a national initiative working hand in hand with trusted leaders and community organizations to continue to build confidence in COVID-19 vaccines and get more people vaccinated. This campaign offers tailored resources and toolkits for stakeholders to use to provide COVID-19 vaccine information to at-risk populations.
  18. Join Doctor Mike Varshavski as he discusses how COVID-19 vaccines work on four levels understandable to a child, parent, student and vaccine expert.
  19. Qui peut se faire vacciner aujourd’hui contre le Covid-19 ? Comment prendre rendez-vous pour cette vaccination ? Quels sont les effets secondaires des vaccins autorisés en France ? Comment la sécurité des vaccins est-elle garantie ? La campagne vaccinale contre le Covid-19 se poursuit et suscite toujours de nombreuses interrogations. Franceinfo s'efforce d’y répondre dans le cadre de son opération #OnVousRépond. Vous trouverez ici nos réponses aux questions les plus fréquentes sur les vaccins contre le Covid-19. Il est possible de compléter avec les sites des autorités sanitaires, les travaux des sociétés savantes (comme ce dossier de la Société de pathologie infectieuse de langue française) et bien entendu auprès de son médecin.
  20. Misinformation threatens the success of vaccination programs across the world. Unicef, First Draft, Yale Institute for Global Health, and PGP (The Public Good Projects) have partnered to create the Vaccine Misinformation Management Field Guide. This guide aims to help organizations to address the global infodemic through the development of strategic and well-coordinated national action plans to rapidly counter vaccine misinformation and build demand for vaccination that are informed by social listening.
  21. La pandémie de Covid-19 ayant causé plus de 100 millions de cas et plus de 2,3 millions de morts à l’échelle mondiale, la publication des résultats des études pivot des premiers candidats-vaccins contre la Covid-19 a été une source d’espoir pour la communauté internationale. De nombreux pays ont rapidement initié une campagne vaccinale contre la Covid19 ; plus de 150 millions de doses ont été administrées dans le monde au 12 février 2021 (https://ourworldindata.org/covid-vaccinations). De nombreuses questions ont été soulevées en France, à la fois par les décideurs en Santé publique, mais aussi très vite par les soignants et acteurs de terrain, en charge d’informer la population, de définir et repérer les personnes prioritaires et de mettre en place la campagne vaccinale en France. Devant cette demande forte d’éclairage simple et objectif des données disponibles, la Société de Pathologie Infectieuse de Langue Française (SPILF) a été sollicitée pour élaborer un document d’information à destination des professionnels de santé.
  22. National Infant Immunization Week (NIIW) is April 24-May 1, 2021. Use the sample key messages, social media content, and materials below in your planning and activities for NIIW to highlight the positive impact of childhood immunization.
  23. This section is an ongoing compilation of tough questions related to COVID-19, with suggested answers. Many of these topics are sensitive and often politicized. The document is designed to provide message guidance and framing for public health officials and others, and it is regularly updated to reflect new developments and emerging issues.
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue. - Terms of Use - Privacy Policy - Guidelines